![Kevin Colbert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Kevin Colbert
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LifeSprout, Inc.
![]() LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Operationeel Directeur | 01-01-2018 | - |
Oprichter | 01-01-2018 | - |
Loopbaan van Kevin Colbert
Eerdere bekende functies van Kevin Colbert
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Glyscend, Inc.
![]() Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Oprichter | 01-09-2014 | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Founder | 2 |
Chief Operating Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
LifeSprout, Inc.
![]() LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Health Technology |
Glyscend, Inc.
![]() Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Health Technology |
- Beurs
- Insiders
- Kevin Colbert
- Ervaring